Senex Biotechnology
1 known investors
Senex Biotechnology develops small-molecule inhibitors targeting protein regulators of gene expression for cancer treatment, with lead programs in prostate cancer, breast cancer, and leukemia. The company is also exploring applications in inflammation and cardiovascular disease.
BiotechHealthtechMedical Devices